Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 12/2016

01-12-2016 | Review

A systematic review of Fusobacterium necrophorum-positive acute tonsillitis: prevalence, methods of detection, patient characteristics, and the usefulness of the Centor score

Authors: T. E. Klug, M. Rusan, K. Fuursted, T. Ovesen, A. W. Jorgensen

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 12/2016

Login to get access

Abstract

The purpose of this study was to review the current evidence for an association between Fusobacterium necrophorum (FN) and acute tonsillitis (AT), to assess the prevalence of FN in AT, to identify the better FN detection method, and to characterize the clinical characteristics of FN-positive patients with uncomplicated AT. A systematic literature search was conducted in the PubMed, EMBASE, and SweMed+ databases for studies reporting on the recovery rates of FN in patients with AT. A total of 498 unique records were identified. Eleven studies were included in a qualitative synthesis and six studies were included in a meta-analysis. Considerable heterogeneity (I2 = 60 %) and risk of bias and confounders was found among the studies, though a subset of studies (prospective) had lower heterogeneity and higher study quality. FN was recovered significantly more frequently from patients (21.2 %) compared to healthy controls (7.6 %) (p < 0.001). FN recovery rates were similar between culture-based studies (20.3 %) and studies using polymerase chain reaction (PCR) methodology (22.2 %) (p = 0.462). The typical FN-positive AT patient was a smoking young (15–25 years) male presenting with tonsillar exudates and a Centor score of 2 or higher. A clear association between FN and AT was found. FN is likely to be a significant and prevalent pathogen in AT, especially in teenagers and young adults. However, no evidence for causality between FN and AT has been established and it is unexplored if timely antibiotic therapy directed against FN accelerates the resolution of symptoms and decreases the risk of complications.
Appendix
Available only for authorised users
Literature
1.
go back to reference ESCMID Sore Throat Guideline Group, Pelucchi C, Grigoryan L, Galeone C, Esposito S, Huovinen P, Little P, Verheij T (2012) Guideline for the management of acute sore throat. Clin Microbiol Infect 18:1–28. doi:10.1111/j.1469-0691.2012.03766.x ESCMID Sore Throat Guideline Group, Pelucchi C, Grigoryan L, Galeone C, Esposito S, Huovinen P, Little P, Verheij T (2012) Guideline for the management of acute sore throat. Clin Microbiol Infect 18:1–28. doi:10.​1111/​j.​1469-0691.​2012.​03766.​x
2.
3.
go back to reference Shulman ST, Tanz RR (2010) Group A streptococcal pharyngitis and immune-mediated complications: from diagnosis to management. Expert Rev Anti Infect Ther 8:137–150CrossRefPubMed Shulman ST, Tanz RR (2010) Group A streptococcal pharyngitis and immune-mediated complications: from diagnosis to management. Expert Rev Anti Infect Ther 8:137–150CrossRefPubMed
4.
go back to reference Centor RM, Witherspoon JM, Dalton HP, Brody CE, Link K (1981) The diagnosis of strep throat in adults in the emergency room. Med Decis Making 1:239–246CrossRefPubMed Centor RM, Witherspoon JM, Dalton HP, Brody CE, Link K (1981) The diagnosis of strep throat in adults in the emergency room. Med Decis Making 1:239–246CrossRefPubMed
5.
go back to reference Tan ZL, Nagaraja TG, Chengappa MM (1996) Fusobacterium necrophorum infections: virulence factors, pathogenic mechanism and control measures. Vet Res Commun 20:113–140CrossRefPubMed Tan ZL, Nagaraja TG, Chengappa MM (1996) Fusobacterium necrophorum infections: virulence factors, pathogenic mechanism and control measures. Vet Res Commun 20:113–140CrossRefPubMed
6.
go back to reference Hagelskjaer Kristensen L, Prag J (2008) Lemierre’s syndrome and other disseminated Fusobacterium necrophorum infections in Denmark: a prospective epidemiological and clinical survey. Eur J Clin Microbiol Infect Dis 27:779–789CrossRefPubMed Hagelskjaer Kristensen L, Prag J (2008) Lemierre’s syndrome and other disseminated Fusobacterium necrophorum infections in Denmark: a prospective epidemiological and clinical survey. Eur J Clin Microbiol Infect Dis 27:779–789CrossRefPubMed
7.
go back to reference Ehlers Klug T, Rusan M, Fuursted K, Ovesen T (2009) Fusobacterium necrophorum: most prevalent pathogen in peritonsillar abscess in Denmark. Clin Infect Dis 49:1467–1472CrossRefPubMed Ehlers Klug T, Rusan M, Fuursted K, Ovesen T (2009) Fusobacterium necrophorum: most prevalent pathogen in peritonsillar abscess in Denmark. Clin Infect Dis 49:1467–1472CrossRefPubMed
8.
go back to reference Klug TE, Henriksen JJ, Fuursted K, Ovesen T (2011) Significant pathogens in peritonsillar abscesses. Eur J Clin Microbiol Infect Dis 30:619–627CrossRefPubMed Klug TE, Henriksen JJ, Fuursted K, Ovesen T (2011) Significant pathogens in peritonsillar abscesses. Eur J Clin Microbiol Infect Dis 30:619–627CrossRefPubMed
9.
go back to reference Klug TE, Henriksen JJ, Rusan M, Fuursted K, Krogfelt KA, Ovesen T, Struve C (2014) Antibody development to Fusobacterium necrophorum in patients with peritonsillar abscess. Eur J Clin Microbiol Infect Dis 33:1733–1739. doi:10.1007/s10096-014-2130-y CrossRefPubMed Klug TE, Henriksen JJ, Rusan M, Fuursted K, Krogfelt KA, Ovesen T, Struve C (2014) Antibody development to Fusobacterium necrophorum in patients with peritonsillar abscess. Eur J Clin Microbiol Infect Dis 33:1733–1739. doi:10.​1007/​s10096-014-2130-y CrossRefPubMed
11.
go back to reference Aliyu SH, Marriott RK, Curran MD, Parmar S, Bentley N, Brown NM, Brazier JS, Ludlam H (2004) Real-time PCR investigation into the importance of Fusobacterium necrophorum as a cause of acute pharyngitis in general practice. J Med Microbiol 53:1029–1035CrossRefPubMed Aliyu SH, Marriott RK, Curran MD, Parmar S, Bentley N, Brown NM, Brazier JS, Ludlam H (2004) Real-time PCR investigation into the importance of Fusobacterium necrophorum as a cause of acute pharyngitis in general practice. J Med Microbiol 53:1029–1035CrossRefPubMed
12.
go back to reference Jensen A, Hagelskjaer Kristensen L, Prag J (2007) Detection of Fusobacterium necrophorum subsp. funduliforme in tonsillitis in young adults by real-time PCR. Clin Microbiol Infect 13:695–701CrossRefPubMed Jensen A, Hagelskjaer Kristensen L, Prag J (2007) Detection of Fusobacterium necrophorum subsp. funduliforme in tonsillitis in young adults by real-time PCR. Clin Microbiol Infect 13:695–701CrossRefPubMed
13.
go back to reference Jensen A, Hansen TM, Bank S, Kristensen LH, Prag J (2015) Fusobacterium necrophorum tonsillitis: an important cause of tonsillitis in adolescents and young adults. Clin Microbiol Infect 21:266.e1–266.e3. doi:10.1016/j.cmi.2014.09.020 CrossRef Jensen A, Hansen TM, Bank S, Kristensen LH, Prag J (2015) Fusobacterium necrophorum tonsillitis: an important cause of tonsillitis in adolescents and young adults. Clin Microbiol Infect 21:266.e1–266.e3. doi:10.​1016/​j.​cmi.​2014.​09.​020 CrossRef
14.
go back to reference Centor RM, Atkinson TP, Ratliff AE, Xiao L, Crabb DM, Estrada CA, Faircloth MB, Oestreich L, Hatchett J, Khalife W, Waites KB (2015) The clinical presentation of Fusobacterium-positive and streptococcal-positive pharyngitis in a university health clinic: a cross-sectional study. Ann Intern Med 162:241–247CrossRefPubMed Centor RM, Atkinson TP, Ratliff AE, Xiao L, Crabb DM, Estrada CA, Faircloth MB, Oestreich L, Hatchett J, Khalife W, Waites KB (2015) The clinical presentation of Fusobacterium-positive and streptococcal-positive pharyngitis in a university health clinic: a cross-sectional study. Ann Intern Med 162:241–247CrossRefPubMed
15.
go back to reference Kjærulff AM, Thomsen MK, Ovesen T, Klug TE (2015) Clinical and biochemical characteristics of patients with Fusobacterium necrophorum-positive acute tonsillitis. Eur Arch Otorhinolaryngol 272:1457–1463CrossRefPubMed Kjærulff AM, Thomsen MK, Ovesen T, Klug TE (2015) Clinical and biochemical characteristics of patients with Fusobacterium necrophorum-positive acute tonsillitis. Eur Arch Otorhinolaryngol 272:1457–1463CrossRefPubMed
16.
go back to reference Batty A, Wren MW (2005) Prevalence of Fusobacterium necrophorum and other upper respiratory tract pathogens isolated from throat swabs. Br J Biomed Sci 62:66–70CrossRefPubMed Batty A, Wren MW (2005) Prevalence of Fusobacterium necrophorum and other upper respiratory tract pathogens isolated from throat swabs. Br J Biomed Sci 62:66–70CrossRefPubMed
17.
go back to reference Amess JA, O’Neill W, Giollariabhaigh CN, Dytrych JK (2007) A six-month audit of the isolation of Fusobacterium necrophorum from patients with sore throat in a district general hospital. Br J Biomed Sci 64:63–65CrossRefPubMed Amess JA, O’Neill W, Giollariabhaigh CN, Dytrych JK (2007) A six-month audit of the isolation of Fusobacterium necrophorum from patients with sore throat in a district general hospital. Br J Biomed Sci 64:63–65CrossRefPubMed
18.
go back to reference Price SL, Hardy S, Gale P, Basten GP (2011) Prevalence of Fusobacterium necrophorum in persistent sore throat samples. Br J Biomed Sci 68:209–210PubMed Price SL, Hardy S, Gale P, Basten GP (2011) Prevalence of Fusobacterium necrophorum in persistent sore throat samples. Br J Biomed Sci 68:209–210PubMed
19.
go back to reference Eaton C, Swindells J (2014) The significance and epidemiology of Fusobacterium necrophorum in sore throats. J Infect 69:194–196CrossRefPubMed Eaton C, Swindells J (2014) The significance and epidemiology of Fusobacterium necrophorum in sore throats. J Infect 69:194–196CrossRefPubMed
20.
go back to reference Ludlam H, Howard J, Kingston B, Donachie L, Foulkes J, Guha S, Curran MD (2009) Epidemiology of pharyngeal carriage of Fusobacterium necrophorum. J Med Microbiol 58:1264–1265CrossRefPubMed Ludlam H, Howard J, Kingston B, Donachie L, Foulkes J, Guha S, Curran MD (2009) Epidemiology of pharyngeal carriage of Fusobacterium necrophorum. J Med Microbiol 58:1264–1265CrossRefPubMed
23.
go back to reference Fine AM, Nizet V, Mandl KD (2012) Large-scale validation of the Centor and McIsaac scores to predict group a streptococcal pharyngitis. Arch Intern Med 172:847–852CrossRefPubMedPubMedCentral Fine AM, Nizet V, Mandl KD (2012) Large-scale validation of the Centor and McIsaac scores to predict group a streptococcal pharyngitis. Arch Intern Med 172:847–852CrossRefPubMedPubMedCentral
25.
go back to reference Brook I (2011) The impact of smoking on oral and nasopharyngeal bacterial flora. J Dent Res 90:704–710CrossRefPubMed Brook I (2011) The impact of smoking on oral and nasopharyngeal bacterial flora. J Dent Res 90:704–710CrossRefPubMed
26.
go back to reference Kordeluk S, Novack L, Puterman M, Kraus M, Joshua BZ (2011) Relation between peritonsillar infection and acute tonsillitis: myth or reality? Otolaryngol Head Neck Surg 145:940–945CrossRefPubMed Kordeluk S, Novack L, Puterman M, Kraus M, Joshua BZ (2011) Relation between peritonsillar infection and acute tonsillitis: myth or reality? Otolaryngol Head Neck Surg 145:940–945CrossRefPubMed
Metadata
Title
A systematic review of Fusobacterium necrophorum-positive acute tonsillitis: prevalence, methods of detection, patient characteristics, and the usefulness of the Centor score
Authors
T. E. Klug
M. Rusan
K. Fuursted
T. Ovesen
A. W. Jorgensen
Publication date
01-12-2016
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 12/2016
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-016-2757-y

Other articles of this Issue 12/2016

European Journal of Clinical Microbiology & Infectious Diseases 12/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.